Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Rain Oncology Inc (NQ: RAIN ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Jan 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open - Bid (Size) 1.210 (26) Ask (Size) 1.240 (146) Prev. Close 1.210 Today's Range N/A - N/A 52wk Range 0.8200 - 1.255 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Pathos AI Completes Acquisition of Rain Oncology January 26, 2024 From Pathos AI, Inc. Via Business Wire RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN January 04, 2024 From Kahn Swick & Foti, LLC Via Business Wire Performance More News Read More BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. January 04, 2024 From Brodsky & Smith LLC Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. December 26, 2023 From Brodsky & Smith LLC Via GlobeNewswire RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN December 18, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alteryx, Inc. (NYSE – AYX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc. December 18, 2023 From Brodsky & Smith LLC Via GlobeNewswire Rain Oncology Goes Private Just Two Years After $120M NASDAQ Debut December 14, 2023 Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders December 14, 2023 From Halper Sadeh LLC Via Business Wire Rain Oncology Inc. (NASDAQ:RAIN) Long Term Investor Notice: Investigation over Possible Wrongdoing October 19, 2023 Via SBWire Rain Oncology And 3 Other Stocks Under $1 Insiders Are Buying October 16, 2023 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Friday's After-Market Session October 13, 2023 Via Benzinga RAIN DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN September 12, 2023 Via TheNewswire.com Topics Lawsuit Exposures Financial Legal RAIN DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN September 12, 2023 Via NewMediaWire Topics Lawsuit Exposures Financial Legal The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN) September 11, 2023 From The Law Offices of Frank R. Cruz Via Business Wire Stocks That Hit 52-Week Lows On Monday September 11, 2023 Via Benzinga RAIN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Rain Oncology, Inc. and Encourages Investors to Contact the Firm September 08, 2023 From Bragar Eagel & Squire, P.C. Via Business Wire ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action – RAIN September 08, 2023 From The Rosen Law Firm PA Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday September 07, 2023 Via Benzinga Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baxter, Rain, and Danaher, and Encourages Investors to Contact the Firm September 06, 2023 From Bragar Eagel & Squire Via GlobeNewswire NASDAQ: RAIN Investor Alert: Deadline on September 12, 2023 in Lawsuit Against Rain Oncology Inc. September 06, 2023 Via SBWire Topics Lawsuit Exposures Financial Legal ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN September 03, 2023 Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, A LEADING NATIONAL FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN September 01, 2023 Via NewMediaWire Topics Lawsuit Exposures Financial Legal Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Seagate, Baxter, and Rain and Encourages Investors to Contact the Firm September 01, 2023 From Bragar Eagel & Squire Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session August 28, 2023 Via Benzinga Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rain, Proterra, and Danaher and Encourages Investors to Contact the Firm August 27, 2023 From Bragar Eagel & Squire Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.